Prof Caroline (Lindy) Rae
TEAM LEADER PROFILE
Conjoint Senior Principal Scientist, NeuRA
Professor of Brain Sciences, UNSW
Director (Medicine) EPICentre, UNSW
Director (Research) NeuRA Imaging
Honorary Associate, Macquarie Centre for Cognitive Science, Macquarie University, Sydney
School of Medical Sciences, UNSW
+612 9399 1211
Prof Caroline Rae is a biochemist with a background in magnetic resonance and interdisciplinary brain research. She graduated with a PhD in biochemistry and NMR from The University of Sydney in 1993 and spent four years in Oxford, UK, as a Nuffield Medical Fellow where she pioneered the use of magnetic resonance spectroscopy as a tool in cognitive brain research. In 2005 she was appointed to UNSW as a New South Global Professor, one of only a handful of NHMRC R Douglas Wright Fellows subsequently appointed to chairs. She is currently director of the UNSW Node of the National Imaging Facility and holds a cross-disciplinary (STEM) appointment in medical data visualisation as a Director of the UNSW Expanded Perception and Interaction Centre (EPICentre).
Projects Prof Caroline (Lindy) Rae is currently involved with
CURRENT PROJECTS
Determining new targets and approaches for treating sleep apnoea
We are running a range of projects to determine how existing treatments for sleep apnoea work so that we can optimise therapy and improve treatment success.READ MORE
Determining new targets and approaches for treating sleep apnoea
Regulation of brain energy metabolism by NAD and sirtuins
This project is investigating control of metabolism by sirtuins and by NAD+ availability using an innovative, pharmacogenetic approach to metabolism research and “world-first” cell-specific introduction of enzymes into tissue in vivo. It will deliver an integrated picture of how SIRTs 1-3 and NAD+ interact with metabolism, crucial for development of next generation treatments based on this system. Finally, in preclinical translation, we will test the therapeutic effects of manipulating this system to combat decreased NAD+ availability and SIRT activity within the aging brain.READ MORE
Regulation of brain energy metabolism by NAD and sirtuins
New methods for analysis and visualisation of metabolic data
We are developing new approaches that allow representation of metabolomic data as a network, while still retaining some elements of data reduction in order to remove the immense complexity associated with analysis.READ MORE
New methods for analysis and visualisation of metabolic data
Brain network discovery in medical research
Scientists discovered some time ago that they could use magnetic resonance imaging (MRI) to map brain activity when a person was repetitively performing a task, like looking at flashing lights or doing serial maths calculations. More recently, they found that these MRI signals could also provide useful information when the scanned subject was not doing anything. They called these signals “resting state” signals. Our new analysis approach for resting state data uniquely provides repeatable, reliable results from single scanning sessions. We are developing methods for network comparison and are applying our new approaches across a targeted range of patient data.READ MORE
Brain network discovery in medical research
Binge drinking and the adolescent brain
This study is examining effects of binge alcohol consumption in 16-17 year olds using questionnaires, magnetic resonance imaging and cognitive testing. It aims to determine whether binge consumption of alcohol is impacting adolescent brain and cognitive development.READ MORE
Binge drinking and the adolescent brain
Novel brain biomarkers of neurobehavioural dysfunction in obstructive sleep apnoea
This study aims to investigate the relationship between brain biomarkers measured at baseline, with neurobehavioural dysfunction during a subsequent extended wakefulness “load” that will uncover the individual variation in neurobehavioral dysfunction in patients with obstructive sleep apnoea.READ MORE
Novel brain biomarkers of neurobehavioural dysfunction in obstructive sleep apnoea
THE EPICENTRE WEBSITE (URL COMING!)
GOOGLE SCHOLAR
RESEARCHER ID
RESEARCH TEAM
BEN ROWLANDS PhD student
JUN CAO PhD student
ABHIJIT DAS PhD student
SALLY MCEWAN PhD student
PUBLICATIONS
Covertly active and progressing neurochemical abnormalities in suppressed HIV infection.
Cysique LA, Jugé L, Gates T, Tobia M, Moffat K, Brew BJ, Rae C
To assess whether HIV-related brain injury is progressive in persons with suppressed HIV infection. Our study reveals covertly active or progressing HIV-related brain injury in the majority of this virally suppressed cohort, reflecting ongoing neuropathogenic processes that are only partially worsened by historical HAND and HIV duration. Longer-term studies will be important for determining the prognosis of these slowly evolving neurochemical abnormalities.
White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration.
Cysique LA, Soares JR, Geng G, Scarpetta M, Moffat K, Green M, Brew BJ, Henry RG, Rae C
The objective of the current study was to quantify the degree of white matter (WM) abnormalities in chronic and virally suppressed HIV-infected (HIV+) persons while carefully taking into account demographic and disease factors. Diffusion tensor imaging (DTI) was conducted in 40 HIV- and 82 HIV+ men with comparable demographics and life style factors. The HIV+ sample was clinically stable with successful viral control. Diffusion was measured across 32 non-colinear directions with a b-value of 1000 s/mm; fractional anisotropy (FA) and mean diffusivity (MD) maps were quantified with Itrack IDL. Using the ENIGMA DTI protocol, FA and MD values were extracted for each participant and in 11 skeleton regions of interest (SROI) from standard labels in the JHU ICBM-81 atlas covering major striato-frontal and parietal tracks. We found no major differences in FA and MD values across the 11 SROI between study groups. Within the HIV+ sample, we found that a higher CNS penetrating antiretroviral treatment, higher current CD4+ T cell count, and immune recovery from the nadir CD4+ T cell count were associated with increased FA and decreased MD (p < 0.05-0.006), while HIV duration, symptomatic, and asymptomatic cognitive impairment were associated with decreased FA and increased MD (p < 0.01-0.004). Stability of HIV treatment and antiretroviral CNS penetration efficiency in addition to current and historical immune recovery were related to higher FA and lower MD (p = 0.04-p < 0.01). In conclusion, WM DTI measures are near normal except for patients with neurocognitive impairment and longer HIV disease duration.
Covertly active and progressing neurochemical abnormalities in suppressed HIV infection.
Cysique LA, Jugé L, Gates T, Tobia M, Moffat K, Brew BJ, Rae C
To assess whether HIV-related brain injury is progressive in persons with suppressed HIV infection. Our study reveals covertly active or progressing HIV-related brain injury in the majority of this virally suppressed cohort, reflecting ongoing neuropathogenic processes that are only partially worsened by historical HAND and HIV duration. Longer-term studies will be important for determining the prognosis of these slowly evolving neurochemical abnormalities.